PRESS RELEASES

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

MOVE-IT met the primary endpoint with statistically significant improvement in gastroparesis symptoms in 20 mg and 40 mg TID doses vs placebo Improvements observed across key symptoms, including nausea, early satiety, post-prandial fullness and upper abdominal pain Favorable safety and tolerability profiles Late-breaking oral presentation delivered at Digestive Disease Week

Read More

EarthDaily Advancing Daily Global Measurement of Planetary Change with Six Satellites Launched

EarthDaily Satellite Deploys MAPLE GROVE, Minn., May 04, 2026 (GLOBE NEWSWIRE) — EarthDaily Analytics (EarthDaily) today announced the successful launch of six EarthDaily Constellation satellites aboard a SpaceX Falcon 9 rideshare mission, confirming initial contact with satellites EDC-02 through EDC-07. The milestone significantly advances the company’s goal of delivering daily,

Read More